rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Collaborative innovation in drug discovery
    sub title: strategies for public and private partnerships
  name:
    name part: Chaguturu, Rathnam
    role:
      role term: editor.
  type of resource: text
  genre: bibliography
  genre: Electronic books.
  origin info:
    place:
      place term: nju
    date issued: 2014
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: remote
    extent: 1 online resource.
  abstract: Can academia save the pharmaceutical industry? The pharmaceutical industry is at a crossroads. The urgent need for novel therapies cannot stem the skyrocketing costs and plummeting productivity plaguing R & D, and many key products are facing patent expiration. Dr. Rathnam Chaguturu presents a case for collaboration between the pharmaceutical industry and academia that could reverse the industry's decline. Collaborative Innovation in Drug Discovery: Strategies for Public and Private Partnerships provides insight into the potential synergy of basing R & D in academia while leaving d.
  table of contents: Table of Contents; Wiley Series on Technologies for the Pharmaceutical Industry; Title page; Copyright page; Dedication; Collaborative Drug Discovery Ethos; Foreword; Preface; About the Book; About the Editor; Contributors; Part I: Perspectives on Collaborative Innovation; 1: Productive Relationships in Research and Development between Government, Industry, and Universities; Universities, Government, and Industry: Historical Beginnings in Prussia; Refinement and Broad Adoption: the United States; General Principles for Success; Notes; 2: Divided We Fall; Challenges; Collaboration Models.
  table of contents: Examples of Successful Biomedical CollaborationsPrinciples of Collaboration; Governance, Administration, and Autonomy; Human Factors; Conclusion; References; 3: Innovation: Open Source and Nonprofit Models in Drug Discovery; Why Do People Innovate?; How Do We Encourage Innovation?; Why Is Innovation Important?; Warnings Regarding Innovation in Drug Discovery; Open Source Models; Nonprofit Models; Recommendations; References; 4: The Changing Face of Innovation in Drug Discovery; Introduction; Core Objectives of the Drug Discovery Process.
  table of contents: Major Innovations in Technology Have Advanced Drug DiscoveryAn Important Trend: Academic and Pharmaceutical Organizations Are Collaborating in Support of Drug Discovery; Future Perspectives: Where Is Innovation Leading?; References; 5: Current Trends in Collaborative Drug Discovery and Strategies to De-Risk Precompetitive Initiatives; Pharmaceutical Industry's Perspective; Academia's Perspective; Open (Collaborative) Innovation: A New Business Model; Drug Discovery through Collaborations; Drug Discovery through Consortia; Drug Discovery through Repurposing Strategies.
  table of contents: Probe Discovery in Public DomainEffective Management of Academia-Pharma Collaborations; Concluding Remarks; References; Notes; 6: A Perspective on the Evolution of Collaborative Drug Discovery and Future Challenges; Evolution of Collaborative Drug Discovery; Challenges for Collaborative Drug Discovery; Conclusion; References; Part II: Governmental Initiatives Accelerate Precompetitive Collaboration; 7: The Value of University-Industry Partnerships; Guiding Principles for University-Industry Collaborations; The Johnson Continuum; Role of Cocreation: Companies, Government, and Universities.
  table of contents: Funding for Collaborations with AcademiaNew Initiatives to Transform University-Industry Collaborations; Issues Affecting University-Industry Collaborations; Differences between Large- and Small-/Medium-Sized Companies; Large Companies Share Certain Characteristics; Small- and Medium-Sized Enterprises (SMEs) Offer a Contrasting Perspective; The National Academies' University-Industry Demonstration Partnership; Strategies for Building High-Value, High Return U-I Partnerships; Conclusion; Note on this Chapter; Note; References.
  note: edited by Dr. Rathnam Chaguturu.
  note: Includes bibliographical references and index.
  subject:
    topic: Drug development
  subject:
    topic: Public-private sector cooperation
  subject:
    topic: Drug Discovery
  subject:
    topic: Public-Private Sector Partnerships
  classification: RM301.25 .C65 2014
  classification: 615.1/9
  classification: QV 745
  related item:
    title info:
      title: Collaborative innovation in drug discovery
    origin info:
      publisher: Hoboken, New Jersey : John Wiley & Sons Inc., [2014]
    identifier: (DLC) 2013035525
  related item:
    title info:
      title: Wiley series on technologies for the pharmaceutical industry
  identifier: 9781118778128
  identifier: 111877812X
  identifier: 9781118778159
  identifier: 1118778154
  identifier: 9781118778166
  identifier: 1118778162
  identifier: 0470917377
  identifier: 9780470917374
  identifier: 9781306571784
  identifier: 1306571782
  identifier: 1118778138
  identifier: 9781118778135
  identifier: 2013035811
  identifier: 1662193 EBL
  identifier: http://proxy.library.tamu.edu/login
  record info:
    record content source: DLC
    record creation date: 130903
    record change date: 20260214200411.3
    record identifier: in00004682395
    language of cataloging:
      language term: eng